
The Goldmine and the Maze: Pure Global's Guide to Launching Orthopedic Surgical Implants in Brazil, Mexico, and Beyond.
LATAM MedTech Insights · Ran Chen
October 3, 20253m 9s
Audio is streamed directly from the publisher (episodes.captivate.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode of LATAM MedTech Insights, we delve into the booming orthopedic surgical implant market across Latin America. We uncover why a successful market-entry strategy requires more than just a great product and existing international approvals. We explore the complex and fragmented regulatory landscapes of key countries like Brazil, Mexico, and Colombia, highlighting the critical differences that can make or break your expansion plans.
We share a cautionary tale of a premier German knee implant company, holding a valid CE mark, that faced a two-year delay in entering the Mexican market. Their mistake was assuming their European clinical data and technical file would suffice. They were caught off guard by COFEPRIS's requirement for in-country biocompatibility testing and their local sales distributor's inability to navigate the intricate submission process, leading to a costly and frustrating stalemate.
Key questions from this episode:
-Why is Brazil's ANVISA known to reject submissions that are easily approved by the FDA or EMA?
-What are the biggest risks of appointing a commercial distributor as your legal registration holder in Mexico?
-How can you leverage your existing approvals to potentially speed up registration in Colombia?
-What are the most common labeling mistakes that lead to rejection by Argentina's ANMAT?
-How do post-market surveillance requirements for orthopedic implants differ between Brazil and Mexico?
-Are there hidden costs associated with improper Spanish and Portuguese technical translations in your dossier?
-Is it possible to build a core technical file that can be adapted for multiple LATAM countries?
-What specific local clinical data do authorities demand for high-risk orthopedic devices?
At Pure Global, we specialize in transforming these regulatory hurdles into market opportunities. We offer end-to-end solutions for MedTech companies, combining deep local expertise in over 30 markets with advanced AI tools to streamline your global market access. Let us be your strategic partner in navigating the complexities of LATAM. Contact us at [email protected] or visit https://pureglobal.com/ to learn more.